A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
Related Experiment Video
Updated: Feb 27, 2026
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.8K
Yingzhu Chen1,2, Shuai Lu2, Hao Jia1,2
1School of Laboratory Medicine and Life Science, Institute of Medical Virology, Wenzhou Medical University, Wenzhou 325035, China.
Emerging Microbes & Infections
|June 29, 2017
Abstract:
This corrects the article DOI: 10.1038/emi.2017.18.
